The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Caris Life Sciences
 
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
Consulting or Advisory Role - Argos Therapeutics
Travel, Accommodations, Expenses - Merck
A phase II trial of risk-adapted treatment for muscle invasive bladder cancer after neoadjuvant accelerated MVAC.
 
Daniel M. Geynisman
Consulting or Advisory Role - Exelixis; Novartis; Pfizer
Research Funding - Genentech (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst)
 
Philip Abbosh
No Relationships to Disclose
 
Matthew R. Zibelman
Consulting or Advisory Role - EMD Serono; Horizon Pharma
Research Funding - Bristol-Myers Squibb; Horizon Pharma
Patents, Royalties, Other Intellectual Property - US Patent No: 15/226,474 filed on 7/1/15 (Inst)
 
Rebecca Feldman
No Relationships to Disclose
 
David James McConkey
Stock and Other Ownership Interests - Apocell
 
Noah M. Hahn
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Health Advances; Inovio Pharmaceuticals; Merck; Oncogenex; Pieris Pharmaceuticals
Research Funding - Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Heat Biologics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Principa Biopharma (Inst)
 
Trinity Bivalacqua
Honoraria - Photocure
 
Edouard John Trabulsi
Consulting or Advisory Role - GenomeDx
 
Costas D. Lallas
No Relationships to Disclose
 
Jean H. Hoffman-Censits
Honoraria - Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Sanofi
Travel, Accommodations, Expenses - Roche/Genentech
 
Rosalia Viterbo
No Relationships to Disclose
 
Eric M. Horwitz
No Relationships to Disclose
 
Thomas M. Churilla
No Relationships to Disclose
 
R. Katherine Alpaugh
No Relationships to Disclose
 
Richard E. Greenberg
No Relationships to Disclose
 
Marc C. Smaldone
No Relationships to Disclose
 
Robert Uzzo
Consulting or Advisory Role - Genentech/Roche; Johnson & Johnson; Pfizer
Speakers' Bureau - Janssen Oncology
Research Funding - Novartis
 
David Chen
No Relationships to Disclose
 
Alexander Kutikov
Employment - Visible Health
Leadership - Visible Health
Stock and Other Ownership Interests - Visible Health
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Genomic Health
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Acceleron Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Horizon Pharma; Inovio Pharmaceuticals; Lilly; Novartis; Pfizer
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst); US Patent No: 15/226,474 files on 7/1/15 (Inst)